Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

GlaxoSmithKline Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jul 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - GlaxoSmithKline Pharmaceuticals Ltd (GLAXO-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Jul 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glaxosmithkline Pharmaceuticals Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Jul 2015 Wright Reports 56 $75.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

03 Jul 2015 GlobalData 44 $125.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

09 Jun 2015 GlobalData 41 $125.00

MOSL: GSK PHARMA (Neutral) - Top line disappoints - margin improvement positive

GSK PHARMA 5QFY15: Top line disappoints; margin improvement positive (GLXO IN, Mkt Cap USD4.4b, CMP INR3276, TP INR3300, 1% ...

19 May 2015 Motilal Oswal Securities Ltd. 12 $115.00

GlaxoSmithkline Pharma (GLXO) - Qtr. Update - Dated - May 19, 2015

GSK Pharma (Bloomberg: GLXO IN; HOLD; TP – Rs 3,005; 8% downside from CMP of Rs 3,276) GSK Pharma’s Q5FY15 adj. PAT (Rs 1....

19 May 2015 Axis Capital Limited 5 $46.00

MOSL: GSK PHARMA (Neutral) - Sharp revenue miss drags 4Q performance

GSK PHARMA 4QCY14: Sharp revenue miss drags 4Q performance (GLXO IN, Mkt Cap USD4.5b, CMP INR3254, TP INR3300, 1% Upside, Ne...

13 Feb 2015 Motilal Oswal Securities Ltd. 10 $104.00

GlaxoSmithkline Pharma (GLXO) - Qtr. Update - Dated - February 12, 2015

GSK Pharma (GLXO IN; HOLD; TP – Rs 2,970; 9% downside from CMP of Rs 3,254). GSK Pharma’s Q4CY14 adj. PAT (Rs 941 mn, dow...

13 Feb 2015 Axis Capital Limited 5 $46.00

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Pharma...

07 Jan 2015 GlobalData 41 $125.00